[Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
MARAS SA, Medical and Regulatory Affairs Services, Cham.
U
U
Kreuter
M
M
Mühlemann
E
E
Vogt
M C
MC
Wohlwend
D000328:Adult; D003692:Delayed-Action Preparations; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D014700:Verapamil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D014700:Verapamil
Vérapamil et hypertension--(étude multicentrique de l'efficacité et de la tolérance de verapamil retard dans le traitement de l'hypertension essentielle).